FrancophonIA/ELRC3.0 huggingface dataset:
English: Cases of malignancies, including cutaneous (i.e. cutaneous T Cell lymphomas) and other types of lymphoma, and skin cancers, have been reported in patients using tacrolimus ointment (see section 4.4).
Maltese: Fost pazjenti li kienu qed jużaw l-ingwent tacrolimus kien hemm każijiet ta' xi malinjitajiet fil-ġilda (jigifieri limfoma tac-cellula tip T) u tipi oħra ta' limfoma, kif ukoll kanċer tal-ġilda (ara sezzjoni 4.4).
English: Desloratadine is moderately bound (83 % - 87 %) to plasma proteins.
Maltese: Desloratadine jintrabat b'mod moderat (83 % - 87 %) mal-proteini tal-plażma.
English: Teva Italia s.r.l.
Maltese: Italia s.r.l.
English: Brampton Road, Hampden Park, Eastbourne East Sussex, BN22 9AG United Kingdom
Maltese: Brampton Road, Hampden Park, Eastbourne East Sussex, BN22 9AG Ir-Renju Unit
English: Indigo carmine aluminium lake (E132) 6.2 Incompatibilities
Maltese: Indigo carmine aluminium lake (E132)
English: Date of latest renewal: 8 August 2016
Maltese: Data tal-aħħar tiġdid: 8 ta' Awwissu 2016
English: Germany info@ratiopharm.de
Maltese: Il-Ġermanja info@ratiopharm.de
English: Pack sizes of 7, 10, 14, 15, 20, 30, 40, 50, 60, 90 and 100 film-coated tablets.
Maltese: Daqsijiet tal-pakketti ta' 7, 10, 14, 15, 20, 30, 40, 50, 60, 90 u 100 pillola miksija b'rita.
English: Teva Operations Poland Sp. Z o.o.
Maltese: Teva Operations Poland Sp. Z o.o. ul.
English: Each tablet contains 14.25 mg of lactose (as monohydrate).
Maltese: Kull pillola fiha 14.25-il mg lactose (bħala monohydrate).
English: Desloratadine ratiopharm 5 mg film-coated tablets are supplied in PVC/PVdC/aluminium blister packs of 7, 10, 14, 15, 20, 30, 40, 50, 60, 90 and 100 film-coated tablets.
Maltese: Desloratadine ratiopharm pilloli ta' 5 mg miksija b'rita jiġu f'pakketti b'folji tal-PVC/PVdC/aluminju ta' 7, 10, 14, 15, 20, 30, 40, 50, 60, 90 u 100 pillola miksija b'rita.
English: Film-coating: polyvinyl alcohol (part. hydrolysed), titanium dioxide (E171), macrogol/PEG 3350, talc and indigo carmine aluminium lake (E132).
Maltese: Il-kisja tal-pillola: polyvinyl alcohol (part. hydrolysed), titanium dioxide (E171), macrogol/PEG 3350, talc u indigo carmine aluminium lake (E132).
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 13 January 2012
Maltese: DATA TAL-EWWEL AWTORIZZAZZJONI/TIĠDID TAL-AWTORIZZAZZJONI Data tal-ewwel awtorizzazzjoni: 13 ta' Jannar, 2012
English: EU/1/11/746/001 - Cartons of 7 film-coated tablets in PVC/PVdC/aluminium blisters EU/1/11/746/002 - Cartons of 10 film-coated tablets in PVC/PVdC/aluminium blisters EU/1/11/746/003 - Cartons of 14 film-coated tablets in PVC/PVdC/aluminium blisters EU/1/11/746/004 - Cartons of 15 film-coated tablets in PVC/PVdC/aluminium blisters EU/1/11/746/005 - Cartons of 20 film-coated tablets in PVC/PVdC/aluminium blisters EU/1/11/746/006 - Cartons of 30 film-coated tablets in PVC/PVdC/aluminium blisters EU/1/11/746/007 - Cartons of 40 film-coated tablets in PVC/PVdC/aluminium blisters EU/1/11/746/008 - Cartons of 50 film-coated tablets in PVC/PVdC/aluminium blisters EU/1/11/746/009 - Cartons of 60 film-coated tablets in PVC/PVdC/aluminium blisters EU/1/11/746/010 - Cartons of 90 film-coated tablets in PVC/PVdC/aluminium blisters EU/1/11/746/011 - Cartons of 100 film-coated tablets in PVC/PVdC/aluminium blisters
Maltese: - Kartun ta' 15-pillola miksija b'rita f'folji tal-PVC/PVdC/aluminju EU/1/11/746/005 - Kartun ta' 20 pillola miksija b'rita f'folji tal-PVC/PVdC/aluminju EU/1/11/746/006 - Kartun ta' 30 pillola miksija b'rita f'folji tal-PVC/PVdC/aluminju EU/1/11/746/007 - Kartun ta' 40 pillola miksija b'rita f'folji tal-PVC/PVdC/aluminju EU/1/11/746/008 - Kartun ta' 50 pillola miksija b'rita f'folji tal-PVC/PVdC/aluminju EU/1/11/746/009 - Kartun ta' 60 pillola miksija b'rita f'folji tal-PVC/PVdC/aluminju EU/1/11/746/010
English: Polyvinyl alcohol (part. hydrolysed) Titanium dioxide (E171) Macrogol/PEG 3350
Maltese: Titanium dioxide (E171) Macrogol/PEG 3350
English: Frequencies are defined as very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000) and not known (cannot be estimated from the available data).
Maltese: Il-frekwenzi huma definiti bħala komuni ħafna (≥ 1/10), komuni (≥ 1/100 sa < 1/10), mhux komuni (≥ 1/1,000 sa < 1/100), rari (≥ 1/10,000 sa < 1/1,000), rari ħafna (< 1/10,000) u mhux magħruf (ma tistax tittieħed stima mid-data disponibbli).
English: Tablet core: poloxamer type 188, citric acid monohydrate, microcrystalline cellulose, maize starch, croscarmellose sodium, lactose monohydrate (see section 2 “Desloratadine ratiopharm contains lactose”), talc,
Maltese: Il-qalba tal-pillola: poloxamer tip 188, citric acid monohydrate, microcrystalline cellulose, maize starch, croscarmellose sodium, lactose monohydrate (ara sezzjoni 2 “Desloratadine ratiopharm fih lactose”), talc.
English: Adults and adolescents (12 years of age and over)
Maltese: Adulti u adolexxenti (minn tnax-il sena 'l fuq)
English: INFORMATION IN BRAILLE Desloratadine ratiopharm 5 mg 17.
Maltese: INFORMAZZJONI BIL-BRAILLE Desloratadine ratiopharm 5 mg
English: In a clinical trial with 578 adolescent patients, 12 through 17 years of age, the most common adverse event was headache; this occurred in 5.9 % of patients treated with desloratadine and 6.9 % of patients receiving placebo.
Maltese: Fi prova klinika li fiha ħadu sehem 578 pazjenti adolexxenti, minn 12 sa 17-il sena, l-aktar każ avers komuni kien uġigħ ta' ras, li seħħ f'5.9 % tal-pazjenti ikkurati b'desloratadine u 6.9 % tal-pazjenti li kienu qed jirċievu plaċebo.
English: 7 film-coated tablets 10 film-coated tablets 14 film-coated tablets 15 film-coated tablets 20 film-coated tablets 30 film-coated tablets 40 film-coated tablets 50 film-coated tablets 60 film-coated tablets 90 film-coated tablets 100 film-coated tablets
Maltese: 7 pilloli miksija b'rita 10 pilloli miksija b'rita 14-il pillola miksija b'rita 15-il pillola miksija b'rita 20 pillola miksija b'rita 30 pillola miksija b'rita 40 pillola miksija b'rita 50 pillola miksija b'rita 60 pillola miksija b'rita 90 pillola miksija b'rita 100 pillola miksija b'rita
English: 6.5 Nature and contents of container PVC/PVdC/aluminium blister:
Maltese: In-natura u tal-kontenitur u ta' dak li hemm ġo fih Folji tal-PVC/PVdC/aluminju:
English: The bioavailability of desloratadine was dose proportional over the range of 5 mg to 20 mg.
Maltese: Il-biodisponibilità ta' desloratadine kienet proporzjonali mad-doża fuq il-medda ta' 5 mg sa 20 mg.
English: Hypersensitivity to the active substance, to any of the excipients listed in section 6.1 or to loratadine.
Maltese: Sensittività eċċessiva għas-sustanza attiva għal kwalunkwe wieћed mill-eċċipjenti elenkati fissezzjoni 6.1, jew għal loratadine.
English: There is no evidence of clinically relevant medicine accumulation following once daily dosing of desloratadine (5 mg to 20 mg) for 14 days.
Maltese: M'hemmx evidenza ta' akkumulu tal-mediċina li jista' jkollu rilevanza klinika wara li jingħata dożaġġ ta' desloratadine darba kuljum (5 mg sa 20 mg) għal 14-il ġurnata.
English: ratiopharm GmbH Graf-Arco-Straße 3 89079 Ulm Germany info@ratiopharm.de
Maltese: ratiopharm GmbH Graf-Arco-Straße 3 89079 Ulm
English: The most frequent of adverse reactions reported in excess of placebo were fatigue (1.2 %), dry mouth (0.8 %) and headache (0.6 %).
Maltese: L-aktar reazzjonijiet avversi frekwenti li kienu rappurtati aktar minn dak tal-plaċebo kienu għejja (1.2 %), ħalq xott (0.8 %), u uġigħ ta' ras (0.6 %).
English: Desloratadine given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials.
Maltese: Desloratadine mogħtija bħala doża waħda kuljum ta' 7.5 mg ma effettwax ilprestazzjonijiet psikomotriċi fi provi kliniċi.
English: The efficacy of desloratadine tablets has not been clearly demonstrated in trials with adolescent patients 12 through 17 years of age.
Maltese: L-effikaċja tal-pilloli desloratadine ma ntwerietx b'mod ċar fi provi bi pazjenti adolexxenti minn 12 sa 17-il sena.
English: Pharmacotherapeutic group: antihistamines - H1 antagonist, ATC code: R06A X27
Maltese: Kategorija farmakoterapewtika: anti-istamini- antagonista
English: Desloratadine is the primary active metabolite of loratadine.
Maltese: Desloratadine huwa l-metabolu attiv ewlieni ta' loratadine.
English: Desloratadine effectively controlled symptoms for 24 hours.
Maltese: Desloratadine itaffi b'mod effettiv s-sintomi għal 24 siegħa.
English: Desloratadine does not inhibit CYP3A4 in vivo, and in vitro studies have shown that the medicinal product does not inhibit CYP2D6 and is neither a substrate nor an inhibitor of P-glycoprotein.
Maltese: Desloratadine ma jimpedixxix CYP3A4 in vivo, u studji in vitro urew li l-prodott mediċinali ma jimpedixxix CYP2D6 u la huwa sottostrat u l-anqas inibitur tal-glajkoproteina-P.
English: Desloratadine ratiopharm contains lactose
Maltese: Desloratadine ratiopharm fih lactose
English: When Desloratadine ratiopharm should be used Desloratadine ratiopharm relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older.
Maltese: Desloratadine ratiopharm itaffi s-sintomi assoċjati ma' rajnajtis allerġiku (infjammazzjoni tal-passaġġi fl-imnieħer ikkawżata minn allerġija, per eżempju hay fever jew allerġija għad-dust mites) fl-adulti u fl-adolexxenti minn 12-il sena 'l fuq.
English: No clinically relevant interactions were observed in clinical trials with desloratadine tablets in which erythromycin or ketoconazole were co-administered (see section 5.1).
Maltese: Ma dehrux interazzjonijiet klinikament rilevanti waqt provi kliniċi bil-pilloli desloratadine li fihom ingħataw erythromycin jew ketoconazole fl-istess ħin (ara sezzjoni 5.1).
English: 6.4 Special precautions for storage Do not store above 30 °C.
Maltese: 6.4 Prekawzjonijiet speċjali għall-ħażna Taħżinx f'temperatura 'l fuq minn 30°C.
English: Hypersensitivity reactions (such as anaphylaxis, angioedema, dyspnoea, pruritus, rash and urticaria) Asthenia
Maltese: Reazzjonijiet ta' sensittività eċċessiva (bħal reazzjonijiet anafilattiċi, anġjoedema, ħakk, raxx u urtikarja) Astenja
English: • if you have poor kidney function.
Maltese: • jekk il-funzjoni tal-kliewi hija batuta.
English: In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with desloratadine were reported in 3 % of patients in excess of those treated with placebo.
Maltese: Fi provi kliniċi ta' medda ta' indikazzjonijiet fosthom rajnajtis allerġiku u urtikarja idjopatika kronika, bid-doża rakkomandata ta' 5 mg kuljum, l-effetti mhux mixtieqa b'desloratadine kien rappurtati fi 3 % tal-pazjenti aktar minn dawk fuq plaċebo.
English: Desloratadine plasma concentrations can be detected within 30 minutes of administration.
Maltese: Il-konċentrazzjonijiet fil-plażma ta' desloratadine ikunu jistgħu jitkejjlu fi żmien 30 minuta minn meta jingħata.
English: In a clinical pharmacology trial desloratadine tablets taken concomitantly with alcohol did not potentiate the performance impairing effects of alcohol (see section 5.1).
Maltese: Fi prova farmakoloġika klinika, pilloli desloratadine li ttieħdu flimkien mal-alkoħol ma żiedux l-effetti li jxekklu l-prestazzjoni tal-alkoħol (ara sezzjoni 5.1).
English: Use caution when taking Desloratadine ratiopharm with alcohol.
Maltese: Oqgħod attent meta tieħu Desloratadine ratiopharm mal-alkoħol.
English: Round, biconvex, blue film-coated tablets.
Maltese: Pilloli tondi, bikonvessi u blu miksija b'rita.
English: Adverse reactions seen with desloratadine
Maltese: Reazzjonijiet avversi li dehru b' desloratadine
English: United Kingdom Teva UK Limited Tel: +44 1977 628500
Maltese: Tel: +44 1977 628500
English: In clinical studies in adults, side effects were about the same as with a dummy tablet.
Maltese: Fi studji kliniċi fl-adulti, l-effetti sekondarji kienu rrapurtati kważi daqs kemm ikun hemm b'pillola finta.
English: In a clinical pharmacology trial, in which desloratadine was administered at a dose of 45 mg daily (nine times the clinical dose) for ten days, no prolongation of QTc interval was seen.
Maltese: Fi prova klinika farmakoloġika, li fiha ingħata desloratadine b'doża ta' 45 mg kuljum (disa' darbiet id-doża klinika) għal għaxart ijiem, ma kienx hemm żieda fit-tul tal-intervall QTc.
English: As a precautionary measure, it is preferable to avoid the use of Desloratadine ratiopharm 5 mg film-coated tablets during pregnancy.
Maltese: Bћala prekawzjoni hu preferribli li ma jintużawx Desloratadine ratiopharm 5 mg pilloli miksija b'rita waqt it-tqala.
English: No clinically relevant changes in desloratadine plasma concentrations were observed in multiple-dose ketoconazole and erythromycin interaction trials.
Maltese: Ma dehrux tibdiliet kliniċi rilevanti tal-konċentrazzjonijiet fil-plażma ta' desloratadine bi provi ta' interazzjoni b'ħafna dożi, ma'ketoconazole u erythromycin.
English: Children
Maltese: Adulti
English: How to take Desloratadine ratiopharm
Maltese: X'fih Desloratadine ratiopharm
English: ● stomach ache
Maltese: ● stonku mdardar
English: Desloratadine ratiopharm 5 mg film-coated tablets is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Maltese: Desloratadine ratiopharm 5 mg pilloli miksija b'rita jintużaw fl-adulti u fl-adolexxenti minn 12-il sena 'l fuq biex jittaffew is-sintomi assoċjati ma': - rajnajtis allerġiku (ara sezzjoni 5.1)
English: Desloratadine ratiopharm is an antiallergy medicine that does not make you drowsy.
Maltese: Desloratadine ratiopharm hija mediċina kontra l-allerġiji li ma traqqdekx.
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Maltese: Informazzjoni dettaljata dwar din il-mediċina tinsab fuq is-sit elettroniku tal-Aġenzija Ewropea dwar ilMediċini http://www.ema.europa.eu.
English: ● unusual weakness
Maltese: ● imġiba mhux normali
English: Desloratadine ratiopharm 5 mg film-coated tablets desloratadine
Maltese: Desloratadine ratiopharm 5 mg pilloli miksija b'rita desloratadine
English: ● liver inflammation ● abnormal liver function tests body movement
Maltese: ● irrekwitezza b'żieda fil-moviment tal-ġisem ● infjammazjoni tal-fwied ● testijiet tal-funzjoni tal-fwied mhux normali
English: Film-coating:
Maltese: ● żieda fil-piż
English: These include inhibiting the release of proinflammatory cytokines such as IL-4, IL-6, IL-8, and IL-13 from human mast cells/basophils, as well as inhibition of the expression of the adhesion molecule P-selectin on endothelial cells.
Maltese: Dawn kienu jinkludu t-tfixkil talħelsien ta' ċitokini li jgħinu l-infjammazzjoni bħal IL-4, IL-6, IL-8 u IL-13 miċ-ċelluli mast/bażofili tal-bniedem, kif ukoll tfixkil fl-espressjoni tal-molekula ta' adeżjoni P-selectin fuq iċ-ċelluli endoteljali.
English: The degree of accumulation of desloratadine was consistent with its half-life (approximately 27 hours) and a once daily dosing frequency.
Maltese: Il-grad ta' akkumulu ta' desloratadine kien jaqbel malhalf-life tiegħu (madwat 27 siegħa) u l-frekwenza ta' dożaġġ ta' darba kuljum.
English: An improvement in pruritus of more than 50 % was observed in 55 % of patients treated with desloratadine compared with 19 % of patients treated with placebo.
Maltese: Titjib fil-ħakk ta' aktar minn 50 % deher f'55 % tal-pazjenti kkurati b'desloratadine imqabbla ma' 19 % kkurati bi plaċebo.
English: In a pharmacokinetic trial in which patient demographics were comparable to those of the general seasonal allergic rhinitis population, 4 % of the subjects achieved a higher concentration of desloratadine.
Maltese: Fi studju farmakokinetiku fejn il-karatteristiċi demografiċi tal-pazjenti kienu jaqblu ma' dawk talpopolazzjoni ġenerali b'rajnajtis allerġiku tal-istaġun, 4 % tas-suġġetti akkwistaw konċentrazzjoni ogħla ta' desloratadine.
English: Desloratadine ratiopharm tablets contains lactose.
Maltese: Il-pilloli Desloratadine ratiopharm fihom lactose.
English: Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H1-receptor antagonist activity.
Maltese: Desloratadine huwa antagonist ta' istamina li ma jħeddilx u li jaħdem fit-tul b'attività agonista għarriċettur-H1 periferali b'mod selettiv.
English: The lack of carcinogenic potential was demonstrated in studies conducted with desloratadine and loratadine.
Maltese: In-nuqqas ta' potenzjal li jikkawża l-kanċer kien intwera bi studji li saru b'desloratadine u loratadine.
English: The safety and efficacy of Desloratadine ratiopharm 5 mg film-coated tablets in children below the age of 12 years have not been established.
Maltese: Is-sigurtà u l-effikaċja ta' Desloratadine ratiopharm 5 mg pilloli miksija b'rita fit-tfal ta' inqas minn 12-il sena ma ġewx determinati s'issa.
English: Non-clinical studies conducted with desloratadine and loratadine demonstrated that there are no qualitative or quantitative differences in the toxicity profile of desloratadine and loratadine at comparable levels of exposure to desloratadine.
Maltese: Studji ta' qabel l-użu kliniku li saru b'desloratadine u loratadine urew li m'hemmx differenzi mill-lat kwalitattiv jew kwantitattiv fil-profil ta' tossiċità ta' desloratadine u loratadine f'livelli komparabbli ta' esponiment għal desloratadine.
English: In a multiple dose clinical trial, in which up to 20 mg of desloratadine was administered daily for 14 days, no statistically or clinically relevant cardiovascular effect was observed.
Maltese: Fi prova klinika b'ħafna dożi, li fiha sa 20 mg desloratadine ingħata kuljum għal 14-il ġurnata, ma kienx hemm effett kardjovaskulari klinikament jew statistikament rilevanti.
English: A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Desloratadine ratiopharm 5 mg film-coated tablets therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Maltese: Gћandha tittieћed deċiżjoni jekk ilmara twaqqafx it-treddigћ jew twaqqafx it-trattament b'Desloratadine ratiopharm 5 mg pilloli miksija b'rita, wara li jiġi kkunsidrat il-benefiċċju ta' treddigћ gћat-tarbija u l-benefiċċju tat-trattament gћallmara.
English: Desloratadine ratiopharm with food, drink and alcohol Desloratadine ratiopharm may be taken with or without a meal.
Maltese: Desloratadine ratiopharm ma' ikel, xorb u alkoħol Desloratadine ratiopharm jista' jittieħed mal-ikel jew waħdu.
English: Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction and development.
Maltese: Tagħrif mhux kliniku ibbażat fuq studji konvenzjonali ta' sigurtà farmakoloġika, effett tossiku minn dożi ripetuti, effett tossiku fuq il-ġeni, riskju ta' kanċer, effett tossiku fuq is-sistema riproduttiva u liżvilupp, ma juri l-ebda periklu speċjali għall-bnedmin.
English: How to store Desloratadine ratiopharm
Maltese: Kif jaħdem Desloratadine ratiopharm
English: In clinical studies with desloratadine, the following side effects were reported as:
Maltese: Fi studji kliniċi b'desloratadine, l-effetti sekondarji li ġejjin kienu rrappurtati bħala:
English: Desloratadine has demonstrated antiallergic properties from in vitro studies.
Maltese: Fi studji in vitro, desloratadine wera karatteristiċi kontra l-allerġiji.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg desloratadine.
Maltese: Kull pillola fiha 5 mg desloratadine.
English: ● slow heartbeat
Maltese: Merckle GmbH
English: Tablet core:
Maltese: Kisja tal-pillola:
English: In addition to the established classifications of seasonal and perennial, allergic rhinitis can alternatively be classified as intermittent allergic rhinitis and persistent allergic rhinitis according to the duration of symptoms.
Maltese: Minbarra l-klassifikazzjonijiet stabbiliti tal-istaġun u perenni, rajnajtis allerġiku jista' minflok ikun klassifikat bħala rajnajtis allerġiku intermittenti u rajnajtis allerġiku persistenti skond kemm idumu ssintomi.
English: What Desloratadine ratiopharm is Desloratadine ratiopharm contains desloratadine which is an antihistamine.
Maltese: X'inhu Desloratadine ratiopharm Desloratadine ratiopharm fih desloratadine li hi antiistamin.
English: Chronic idiopathic urticaria was studied as a clinical model for urticarial conditions, since the underlying pathophysiology is similar, regardless of etiology, and because chronic patients can be more easily recruited prospectively.
Maltese: Urtikarja idjopatika kronika kienet studjata bħala mudell kliniku għall-kundizzjonijiet bl-urtikarja, peress li l-patofiżjoloġija warajhom hija simili, irrispettivament mill-etjoloġija, u peress li pazjenti kroniċi jistgħu jiġu ngaġġati aktar faċilment b'mod prospettiv.
English: Fertility There are no data available on male and female fertility.
Maltese: Fertilità M'hemmx dejta disponibbli dwar il-fertilità fl-irġiel jew fin-nisa.
English: No significant differences were found in the psychomotor test results between desloratadine and placebo groups, whether administered alone or with alcohol.
Maltese: Ma kienx hemm differenzi sinjifikanti bejn ir-riżultati ta' testijiet psikomotorjali fil-gruppi ta' desloratadine u plaċebo, kemm meta kien mogħti waħdu kif ukoll mal-alkoħol.
English: After oral administration, desloratadine selectively blocks peripheral histamine H1-receptors because the substance is excluded from entry to the central nervous system.
Maltese: Wara li jingħata b'mod orali, desloratidine jimblokka ir-riċetturiH1 b'mod selettiv għaliex is-sustanza ma titħalliex tidħol fi-sistema nervuża ċentrali.
English: Elevations of liver enzymes, increased bilirubin, hepatitis Jaundice
Maltese: Żieda fl-enżimi tal-fwied, żieda filbilirubina, epatite Suffejra
English: ● vomiting
Maltese: ● ngħas
English: How Desloratadine ratiopharm works
Maltese: Kif gћandek tieћu Desloratadine ratiopharm
English: FI-24100 Salo
Maltese: FI-24100
English: Rare (≥ 1/10,000 to < 1/1,000)
Maltese: Rari (≥ 1/10,000 to < 1/1,000)
English: EU/1/96/004/002 100 tablets
Maltese: EU/1/96/004/002 100 pillola
English: tablet 30 tablets 100 tablets
Maltese: pillola 30 pillola 100 pillola
English: microcrystalline cellulose, colloidal anhydrous silica and magnesium stearate.
Maltese: microcrystalline cellulose, colloidal anhydrous silica u magnesium stearate.
English: INFORMATION IN BRAILLE fareston 60 mg
Maltese: INFORMAZZJONI BIL-BRAILLE fareston 60 mg
English: Package sizes: 30 and 100 tablets.
Maltese: Daqs tal-pakkett: 30 u 100 pillola.
English: Fareston contains the active substance toremifene, an anti-estrogen.
Maltese: Fareston fih is-sustanza attiva toremifene, li hija anti-estroġenu.
English: Date of latest renewal: 2 February 2006
Maltese: 2 ta' Frar 2006
English: Fareston 60 mg tablets toremifene
Maltese: Fareston 60 mg pilloli toremifene
English: - The other ingredients are maize starch, lactose monohydrate, povidone, sodium starch glycolate,
Maltese: - Is-sustanzi l-oħrajn huma maize starch, lactose monohydrate, povidone, sodium starch glycolate,
English: Toremifene binds extensively (> 99.5%) to serum proteins, mainly to albumin.
Maltese: Toremifene jintrabat ħafna (> 99.5%) mal-proteini tas-serum, l-iktar malalbumina.
English: It is bound to plasma proteins even more extensively than toremifene, the protein bound fraction being > 99.9%.
Maltese: Il-metabolita jintrabat mal-proteini tal-plażma b'mod iżjed estensiv minn toremifene, il-frazzjoni marbuta mal-proteini hi ta' > 99.9%.
English: LIST OF EXCIPIENTS lactose monohydrate
Maltese: TA' EĊĊIPJENTI lactose monohydrate